The Venture Codex Logo

The Venture Codex

Orange Grove Bio

201 E 5th St., Suite 2505, Cincinnati, OH, 45202, United States

Overview

Preclinical drug investment and development platform for therapies.

Founded

2019

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

Seed

Geographic focus

United States

Sector focus

Alternative Medicine
Biotechnology
Health Care
Life Science

Investment portfolio

1rounds
NAMEDATESIZE
IpiNovyx Bio
Oct 2021Participated
$10 MSeed
IpiNovyx Bio
Oct 2021Participated
$10 MSeed
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Orange Grove Bio: 1 funding rounds are recorded in the selected participation categories.All available history.
Orange Grove Bio: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01

Monthly Deal Activity

Orange Grove Bio: 1 deals are recorded across 61 months.All available history.
Orange Grove Bio: 1 deals are recorded across 61 months. All available history
MonthDeals
Oct '211
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Orange Grove Bio: Health & Life Sciences is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Orange Grove Bio: Health & Life Sciences is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Health & Life Sciences1

Deal Size Distribution

Orange Grove Bio: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Orange Grove Bio: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Orange Grove Bio: United States has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Orange Grove Bio: United States has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
United States1
Orange Grove Bio: 4 co-investors are shown, with Alexandria Venture Investments sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Orange Grove Bio: 4 co-investors are shown, with Alexandria Venture Investments sharing 1 recorded deals. All available history
Co-investorShared deals
Alexandria Venture Investments1
Eli Lilly and Company1
Opaleye Management1
Viva BioInnovator1

Investment Strategy

Orange Grove Bio: Led accounts for 0% and participating for 100% of round participation.All available history.
Orange Grove Bio: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating1100%
Orange Grove Bio: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Orange Grove Bio: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Marc Spencer Appel

Chief Executive Officer

Ryan Fox

Chief Business Operations Officer